Skip to main content
CARBIOS logo

CARBIOS — Investor Relations & Filings

Ticker · ALCRB ISIN · FR0011648716 LEI · 969500M2RCIWO4NO5F08 PA Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2023-02-02 Regulatory Filings
Country FR France
Listing PA ALCRB

About CARBIOS

https://www.carbios.com/en/

Carbios is a biotechnology company that develops and industrializes biological processes for the end-of-life of plastics and textiles. The company has pioneered an enzymatic recycling technology that uses a proprietary enzyme to depolymerize polyethylene terephthalate (PET) plastic back into its core monomers. This process enables the recycling of all types of PET waste, including complex materials that are difficult to recycle with conventional methods, without any loss of quality. The resulting monomers can be used to produce new, 100% recycled and fully recyclable PET products, establishing a circular economy for plastics.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated February 2, 2023, announcing the successful conclusion of the CE-PET project, which demonstrated Carbios's biorecycling technology on PET textiles. It details technical achievements, quotes management, and provides company background. This format—a formal announcement of a significant operational or research milestone, often released to the public and investors—is characteristic of an Earnings Release (ER) if it were focused on financial results, or more generally, a Regulatory Filing (RNS) if it doesn't fit a specific financial report type. Since it is a detailed announcement of a technological/project success rather than a standard periodic financial report (like 10-K or IR), and it is not a transcript (CT), presentation (IP), or management discussion (MDA), the most appropriate general category for a significant, non-standard corporate update that is not a specific financial filing is Regulatory Filings (RNS). It is not short enough to be a simple RPA, as it contains substantial detail about the project outcomes.
2023-02-02 French
Inside Information / Other news releases
Board/Management Information Classification · 100% confidence The document is explicitly titled 'PRESS RELEASE' and announces specific personnel changes: the appointment of Martine BRISSET and Delphine DENOIZÉ to the Executive Committee. This content directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management. It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2023-01-26 English
Informations privilégiées / Autres communiqués
Board/Management Information Classification · 100% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) and announces specific changes within the company's leadership structure, namely the reinforcement of the Executive Committee (Comité Exécutif) through the appointment of two new members (Martine BRISSET and Delphine DENOIZÉ). This content directly relates to announcements concerning the company's board of directors or senior management changes. Therefore, the appropriate classification is Board/Management Information (MANG). The document is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2023-01-26 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) and announces a strategic, exclusive, and long-term partnership between Carbios and Novozymes regarding PET biorecycling enzymes. It details a business development agreement, not a mandatory regulatory filing like a 10-K, an earnings report (ER), or a formal shareholder communication (like DEF 14A or AGM-R). Since it is a press release announcing a significant business development (a strategic partnership and supply agreement), it falls best under the general category for non-standard regulatory announcements or corporate news releases. Given the provided definitions, 'Regulatory Filings' (RNS) serves as the best fallback for significant corporate news that doesn't fit the highly specific financial or governance categories. It is not a Call Transcript (CT), Director's Dealing (DIRS), or a formal financial report (IR, 10-K).
2023-01-12 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is explicitly titled 'PRESS RELEASE' and announces a strategic partnership between Carbios and Novozymes regarding enzyme supply for PET biorecycling technology. This type of announcement, detailing business developments, collaborations, and strategic updates, is characteristic of a general corporate announcement. Since it is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR), and it is not a transcript (CT) or a proxy statement (DEF 14A/PSI), the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for miscellaneous corporate announcements that do not fit the highly specific financial reporting codes. The document length (7439 chars) is substantial enough that it is the primary announcement itself, not just a brief notice of publication (RPA).
2023-01-12 English
Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract
Regulatory Filings Classification · 95% confidence The document is explicitly titled "PRESS RELEASE" and discusses the "Report on Carbios' liquidity contract with Natixis ODDO BHF," detailing share balances, execution numbers, and traded volumes for the period ending December 31, 2022. This type of regular disclosure regarding market making or liquidity provision activities is a specific type of regulatory announcement concerning the company's stock trading mechanics, often mandated by market authorities (like the AMF mentioned). It is not a full annual report (10-K), an earnings release (ER), or a management discussion (MDA). Since it is a formal, regulated press release detailing specific market activity and is not a general announcement about *when* a major report will be released (RPA), the most appropriate classification is the general regulatory filing category, RNS, as it covers mandatory, specific regulatory disclosures that don't fit the other specialized codes.
2023-01-09 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.